Form 4 for PALI PALISADE BIO, INC.
Accepted 2024-02-01 00:00:00 ET · period of report 2024-01-31 · accession 0001493152-24-004565 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-02-01 | 2024-01-31 | PALI | Williams Donald Allen | Dir | P - Purchase | $0.61 | +10.0K | 30.0K | +50% | +$6,100 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.01 | 2024-01-31 | P | A | 10,000 | $0.61 | 30,000 | I By Reporting Person's Defined Benefit Plan | — | — | (F1) Reporting Person purchased 10,000 shares of Common Stock of Issuer at a price per share of $0.605 on January 31, 2024. |